Atlas Trials

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

Clinical trial NCT01604928 · COMPLETED

Trial details

NCT number
NCT01604928
Sponsor
Astellas Pharma Europe B.V.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Urinary Bladder, Overactive
Start date
2004-04-05
Primary completion
2005-01-25
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.